Cryptococcal Meningoencephalitis With Herpes Zoster Coinfection in a Retrovirus-Positive Adolescent Male With a

Mrunalini Kulkarni1, Unmesh R Sawant2, Nidhisha Kakarla2

  • 1Pediatrics and Neonatology, Bharati Vidyapeeth (Deemed to be University) Medical College and Hospital, Sangli, IND.

Cureus
|May 16, 2025
PubMed

Insights

Cryptococcal meningoencephalitis, a severe opportunistic infection, is rising globally. This report details a rare case of cryptococcal meningoencephalitis with herpes zoster coinfection in an HIV patient with a normal CD4 count.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Immunology

Background:

  • Cryptococcal meningoencephalitis is a life-threatening opportunistic infection caused by *Cryptococcus* species, primarily affecting immunocompromised individuals.
  • The infection, transmitted via inhaled spores, can disseminate to the central nervous system (CNS), leading to severe neurological complications.
  • An increasing global incidence of cryptococcal infections presents a significant public health challenge despite available antifungal treatments.

Observation:

  • *Cryptococcus neoformans* predominantly affects immunocompromised patients' CNS, while *Cryptococcus gattii* typically affects immunocompetent individuals' pulmonary system.
  • Symptoms include fever, headache, altered mental status, and potentially seizures and blindness.
  • Coinfections with other pathogens can complicate diagnosis and treatment outcomes.

Findings:

  • This case report describes a rare instance of cryptococcal meningoencephalitis co-occurring with herpes zoster infection.
  • The patient was diagnosed with Human Immunodeficiency Virus (HIV) but maintained a normal CD4 count.
  • The coinfection presented a unique clinical challenge in an HIV-positive individual with preserved immune function.

Implications:

  • Timely diagnosis and prompt treatment are crucial for improving patient outcomes and reducing mortality associated with cryptococcal meningoencephalitis.
  • Understanding rare coinfections is vital for effective management strategies, especially in the context of rising global fungal infections.
  • This case highlights the need for vigilance in diagnosing and managing opportunistic infections, even in patients with seemingly normal immune parameters.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
862
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
4.9K